Most of these tumor-related alterations belong to the kinases from the closest animal counterpart RTKs, such as RON, FGFR1-4, IGF-1R, ALK, c-Ret, c-Met, and HER-2 (Bhullar et al., 2018). This evidence concerns the gene ERBB2 and neoplasm.